In their study of 252 patients diagnosed with arrhythmogenic right ventricular dysplasia (ARVD) and a positive genetic mutation for DSP, Gasperetti and colleagues demonstrated that 37.3% of patients experienced a ventricular arrhythmic event following a follow-up period of at least 44.5 months. This evidence concerns the gene DSP and Arrhythmogenic right ventricular dysplasia.